6.625 – Long-Term Implantable Ventricular Assist Devices (VADs) and Total Artificial Hearts (TAHs)

Long-term implantable ventricular assist devices (VADs) and total artificial hearts (TAHs) are two of the most sophisticated medical devices ever. This chapter surveys the historical development, evolution, and status of the field, highlighting the four generations of VADs from (1) positive displacement (pulsatile) pumps, through (2) mechanically and (3) hydrodynamically supported rotary blood pumps to (4) pumps whose impellers are fully magnetically levitated. The clinical need and the present and potential future uses of these devices are also highlighted, covering the spectrum from bridge-to-transplant to destination therapy (DT) and potentially bridge-to-recovery. Given their predominant clinical use, long-term implantable LVADs are the primary focus, while TAHs are also described. Anatomical and physiological considerations in device design are outlined. Distinction is made between full-support devices and partial support devices. Key devices representative of each generation are described, including a summary of their design configuration, technological innovations, especially those that are biomaterials related, development status, clinical results, and future plans. The intent is to provide a representative overview to promote an understanding of the field and the various technologies, rather than provide an exhaustive and detailed summary description of every MCS device ever developed.

[1]  Atsushi Takeda,et al.  Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes. , 2005, Cardiovascular research.

[2]  Xinwei Song,et al.  TRANSIENT COMPUTATIONAL FLUID DYNAMICS STUDY OF AN AXIAL BLOOD PUMP , 2003 .

[3]  M. Debakey,et al.  Development of mechanical heart devices. , 2005, The Annals of thoracic surgery.

[4]  J F Antaki,et al.  HeartMate II left ventricular assist system: from concept to first clinical use. , 2001, The Annals of thoracic surgery.

[5]  Mark S Slaughter,et al.  Transcutaneous Energy Transmission for Mechanical Circulatory Support Systems: History, Current Status, and Future Prospects , 2010, Journal of cardiac surgery.

[6]  B. Griffith,et al.  Clinical outcomes are similar in pulsatile and nonpulsatile left ventricular assist device recipients. , 2007, The Annals of thoracic surgery.

[8]  Biswajit Kar,et al.  First clinical use of the redesigned HeartMate II left ventricular assist system in the United States: a case report. , 2004, Texas Heart Institute journal.

[9]  N. Smedira,et al.  Total artificial heart. , 2012, Best practice & research. Clinical anaesthesiology.

[10]  F. Pagani Continuous-flow rotary left ventricular assist devices with "3rd generation" design. , 2008, Seminars in thoracic and cardiovascular surgery.

[11]  Roland Hetzer,et al.  First experiences with a novel magnetically suspended axial flow left ventricular assist device. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[12]  Y. Toyoda,et al.  Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  M. Oz,et al.  Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. , 2001, The Journal of thoracic and cardiovascular surgery.

[14]  Paul E. Allaire,et al.  Axial Flow Blood Pumps , 2003, ASAIO journal.

[15]  David Kaye,et al.  Initial clinical experience with the VentrAssist left ventricular assist device: the pilot trial. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[16]  Christoph Schmidt,et al.  First clinical experience with the Incor left ventricular assist device. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  Satoshi Saito,et al.  First permanent implant of the Jarvik 2000 Heart , 2000, The Lancet.

[18]  David Kaye,et al.  A prospective, multicenter trial of the VentrAssist left ventricular assist device for bridge to transplant: safety and efficacy. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[19]  K. Franco New Devices for Chronic Ventricular Support , 2001, Journal of cardiac surgery.

[20]  Kenneth R. Foster,et al.  LVAD as destination therapy-the economic dilemma , 2004, IEEE Technology and Society Magazine.

[21]  R K Wampler,et al.  Circulatory support of cardiac interventional procedures with the Hemopump cardiac assist system. , 1994, Cardiology.

[22]  C. Hörmann,et al.  Coagulation monitoring and management of anticoagulation during cardiac assist device support. , 2003, The Annals of thoracic surgery.

[23]  M. Oz,et al.  Heart transplant and left ventricular assist device costs. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[24]  Yoshifumi Naka,et al.  Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[25]  R Kormos,et al.  CardioWest total artificial heart: a retrospective controlled study. , 1999, Artificial organs.

[26]  Daniel Tamez,et al.  HeartWare miniature axial-flow ventricular assist device: design and initial feasibility test. , 2009, Texas Heart Institute journal.

[27]  B. Meyns,et al.  Long-term management of an implantable left ventricular assist device using low molecular weight heparin and antiplatelet therapy: a possible alternative to oral anticoagulants. , 2007, Artificial organs.

[28]  Anita Tierney,et al.  Neurological Events During Long-Term Mechanical Circulatory Support for Heart Failure: The Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Experience , 2004, Circulation.

[29]  Gino Gerosa,et al.  Influence of inflow cannula length in axial-flow pumps on neurologic adverse event rate: results from a multi-center analysis. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[30]  B. Yawn,et al.  Trends in heart failure incidence and survival in a community-based population. , 2004, JAMA.

[31]  J T Watson,et al.  The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. , 1999, The Annals of thoracic surgery.

[32]  O H Frazier,et al.  Use of a continuous-flow device in patients awaiting heart transplantation. , 2007, The New England journal of medicine.

[33]  Heinrich Schima,et al.  The DuraHeart VAD, a magnetically levitated centrifugal pump: the University of Vienna bridge-to-transplant experience. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[34]  G Laufer,et al.  First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation. , 2000, Circulation.

[35]  A. Moskowitz,et al.  The cost of long-term LVAD implantation. , 2001, The Annals of thoracic surgery.

[36]  Robert A. Peura,et al.  Cardiac Assist Devices , 1986, IEEE Engineering in Medicine and Biology Magazine.

[37]  J. Osorio Device therapy: Continuous-flow LVAD improves quality of life , 2010, Nature Reviews Cardiology.

[38]  D J Burke,et al.  The Heartmate II: design and development of a fully sealed axial flow left ventricular assist system. , 2001, Artificial organs.

[39]  M. Morshuis,et al.  European experience of DuraHeart magnetically levitated centrifugal left ventricular assist system. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[40]  D. Goldstein,et al.  Worldwide Experience With the MicroMed DeBakey Ventricular Assist Device® as a Bridge to Transplantation , 2003, Circulation.

[41]  W. Cohn,et al.  In vivo evaluation of the HeartWare centrifugal ventricular assist device. , 2007, Texas Heart Institute journal.

[42]  John Woodard,et al.  VentrAssist left ventricular assist device: clinical trial results and Clinical Development Plan update. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[43]  James W Long,et al.  First human implantation of a new rotary blood pump: design of the clinical feasibility study. , 2006, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[44]  Christoph Benk,et al.  Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.